NeuroOne Medical Technologies Corporation (NMTC)
- Previous Close
0.5354 - Open
0.5600 - Bid --
- Ask --
- Day's Range
0.5420 - 0.5900 - 52 Week Range
0.3950 - 1.3900 - Volume
384,040 - Avg. Volume
269,549 - Market Cap (intraday)
27.948M - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2600 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
nmtc1.comRecent News: NMTC
View More
Performance Overview: NMTC
Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NMTC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NMTC
View MoreValuation Measures
Market Cap
25.37M
Enterprise Value
24.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.65
Price/Book (mrq)
8.64
Enterprise Value/Revenue
4.27
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-125.02%
Return on Assets (ttm)
-68.86%
Return on Equity (ttm)
-195.50%
Revenue (ttm)
5.75M
Net Income Avi to Common (ttm)
-7.19M
Diluted EPS (ttm)
-0.2600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.13M
Total Debt/Equity (mrq)
11.64%
Levered Free Cash Flow (ttm)
-4.76M